September 2009 Briefing - Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for September 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Bacterial Infections Are a Factor in Many H1N1 Deaths
WEDNESDAY, Sept. 30 (HealthDay News) -- Many patients who have died of H1N1 influenza this year had a bacterial co-infection that likely contributed to their deaths, according to a Sept. 29 early release of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
H1N1 Virus's Genetic Makeup Appears to Be Staying Stable
MONDAY, Sept. 28 (HealthDay News) -- The genetic makeup of the H1N1 flu has remained stable, which means the yet-to-be-released vaccine is likely to be a good match for the virus, the U.S. Centers for Disease Control and Prevention announced at a Sept. 25 media briefing.
Procedure Compares Well for Sleep Apnea Treatment
THURSDAY, Sept. 24 (HealthDay News) -- Multilevel radiofrequency tissue volume reduction may offer similar improvements in sleep apnea-related symptoms compared to nasal continuous positive airway pressure (CPAP), according to research published in the September issue of the Archives of Otolaryngology -- Head & Neck Surgery.
Study Explores Head, Neck Cancer Radiation Completion
THURSDAY, Sept. 24 (HealthDay News) -- In patients with head and neck cancer, having surgery or chemotherapy may influence their likelihood of completing radiotherapy, according to research published in the September Archives of Otolaryngology -- Head & Neck Surgery.
Review Advises Hand Washing, Other Antiviral Measures
WEDNESDAY, Sept. 23 (HealthDay News) -- Hand washing, wearing a mask, and isolating potential cases are all effective in interrupting the spread of viral respiratory infections and should be given greater attention when planning for widespread outbreaks, according to research published Sept. 22 in BMJ.
Surgeries Offering Relief for Excessive Drooling Analyzed
WEDNESDAY, Sept. 23 (HealthDay News) -- Most patients with drooling will report improvement in symptoms following surgical treatment, according to research published in the September issue of the Archives of Otolaryngology -- Head & Neck Surgery.
Rhinoplasty Patients Typically Want the 'Ideal Nose'
WEDNESDAY, Sept. 23 (HealthDay News) -- Rhinoplasty patients typically want results in line with the ideal parameters established by Powell and Humphreys, a common reference for the procedure, and computer imaging can help define patients' preferences, according to a study published in the September/October issue of the Archives of Facial Plastic Surgery.
Spotlight on Social Networking Use Among Medical Students
TUESDAY, Sept. 22 (HealthDay News) -- A majority of medical schools report instances of medical students posting unprofessional content on social networking Web sites, including some instances of violations of patient confidentiality, according to a report in the Sept. 23/30 issue of the Journal of the American Medical Association.
Most Pediatric Emergency Asthma Cases Not Followed Up
FRIDAY, Sept. 18 (HealthDay News) -- In reference to children with asthma who are seen at a hospital emergency room, most cases are never followed up and the mother's education level is associated with odds of a child being taken for a check-up, according to a study published in the September issue of the Journal of Emergency Nursing.
Taxes on Sugared Sodas Could Cut Consumption
WEDNESDAY, Sept. 16 (HealthDay News) -- Imposing a tax on sugar-sweetened beverages could reduce consumption and generate income for obesity reduction and healthy eating education interventions, according to an article published online Sept. 16 in the New England Journal of Medicine.
FDA Approves Four Vaccines for H1N1 Influenza
TUESDAY, Sept. 15 (HealthDay News) -- The U.S. Food and Drug Administration has approved four H1N1 influenza vaccines, according to a Sept. 15 news release issued by the agency.
Drug Interaction E-Alerts Show Benefit to Patient Safety
MONDAY, Sept. 14 (HealthDay News) -- Drug interaction alerts from electronic prescribing likely improve patient safety and reduce costs in outpatient care, despite the fact that over 90 percent of the alerts are overridden by physicians, according to a study in the Sept. 14 issue of Archives of Internal Medicine.
Mutated H1N1 Virus Resistant to Antiviral Drug Oseltamivir
FRIDAY, Sept. 11 (HealthDay News) -- The discovery of H1N1 mutations resistant to the neuraminidase inhibitor oseltamivir in two adolescent girls sharing a cabin at a North Carolina camp prompted a new recommendation from the U.S. Centers for Disease Control and Prevention on the proper prophylactic use of antiviral drugs, according to a case report in the Sept. 11 issue of the CDC's Morbidity and Mortality Weekly Report.
S. pneumoniae Leads to Death in Many Under 5
FRIDAY, Sept. 11 (HealthDay News) -- Approximately 11 percent of all deaths in children aged 1 to 59 months are due to infection with Streptococcus pneumoniae, and greater efforts to prevent and treat disease associated with the bacterium could help attain the United Nations Millennium Development Goal 4 of reducing child mortality by two-thirds between 1990 and 2015, according to a study published in the Sept. 12 issue of The Lancet.
One Dose of H1N1 Vaccine May Offer Substantial Protection
FRIDAY, Sept. 11 (HealthDay News) -- Preliminary research indicates that just a single dose of the 2009 H1N1 vaccine can substantially increase protective antibodies, but vaccinations with seasonal flu vaccine provide minimal cross-reactive antibody response, according to several studies published online Sept. 10 in the New England Journal of Medicine.
Most H1N1 Flu Patients Don't Need Antiviral Medication
WEDNESDAY, Sept. 9 (HealthDay News) -- Antiviral medications should be used to treat H1N1 swine flu only in people who are hospitalized from the flu or are at high risk of complications from it, according to the U.S. Centers for Disease Control and Prevention.
H1N1 Vaccines Appear Safe for Adults, Children
MONDAY, Sept. 7 (HealthDay News) -- The new H1N1 swine flu vaccine appears to be as safe as the seasonal flu variety, according to experts from the U.S. National Institute of Allergy and Infectious Diseases; and, intravenous use of the antiviral zanamivir (Relenza) may provide a lifesaving alternative for severe cases of H1N1 pneumonitis, according to a report published online Sept. 4 in The Lancet.
Nadroparin May Prevent Blood Clots During Chemotherapy
WEDNESDAY, Sept. 2 (HealthDay News) -- In patients receiving chemotherapy for metastatic or locally advanced solid cancer, nadroparin may reduce the risk of thromboembolic events, according to a study published online Sept. 1 in The Lancet Oncology.
Academic Medical Centers Active and Diverse in Research
TUESDAY, Sept. 1 (HealthDay News) -- Research at academic medical centers is active and diverse, with nearly a quarter of life-science researchers receiving no funding, and relationships with industry more commonly seen among translational and clinical researchers than basic science researchers, according to a study in the Sept. 2 issue of the Journal of the American Medical Association.